Navigation Links
STAAR Surgical To Present At Upcoming Investor Conferences
Date:5/21/2013

MONROVIA, Calif., May 21, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in three upcoming investor conferences to review the Company's recent financial results and business developments with investors and interested parties.

STAAR Surgical will present at the 38th Annual Deutsche Bank 2013 Healthcare Conference in Boston at the Westin Waterfront Hotel on Wednesday, May 29, 2013 at 10:40 a.m. ET.  Barry G. Caldwell , President and CEO and Hans Blickensdoerfer, President, Europe, Middle East, Africa, will be presenting at the conference.

The Benchmark Company One-on-One Investor Conference will be held on Thursday, May 30, 2013 at the Pfister Hotel in Milwaukee, Wisconsin.  Barry Caldwell and Hans Blickensdoerfer will meet with interested investors in a series of one-on-one meetings.

The Company will also present at the Jefferies 2013 Global Healthcare Conference at the Grand Hyatt Hotel in New York on Thursday, June 6, 2013 at 2:00 p.m. ET.  Barry Caldwell and Sam Gesten , General Counsel, will be presenting at the conference.

STAAR will offer a live video webcast of its presentations at Deutsche Bank and Jefferies on the Company's website, www.staar.com, under Investor Information. An archived replay of these presentations will be available for 90 days following the event date, also at www.staar.com.  The Benchmark conference does not provide for companies to webcast the event.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.CONTACT:

Investors

MediaEVC Group

EVC GroupDouglas Sherk, 415-652-9100

Amy Phillips, 412-327-9499 Leigh Salvo, 415-568-9348
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
2. STAAR Surgical Provides Preliminary First Quarter Revenue Results
3. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
4. STAAR Surgical Reports Third Quarter 2012 Financial Results
5. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
6. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
7. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
8. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
9. STAAR Surgical Reports Second Quarter 2012 Financial Results
10. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
11. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Research and Markets has announced the addition of ... offering. ... This report analyzes the worldwide markets for Endodontic Supplies in US$ Thousand. ... , Japan , Europe , ... Annual estimates and forecasts are provided for the period 2015 through ...
(Date:12/8/2016)... 8, 2016   TriNetX , the health ... Hospital signed a membership agreement to join ... of new cures. The TriNetX network ... million patients globally, biopharmaceutical companies and contract research ... protocol design, site selection, patient recruitment, and collaborative ...
(Date:12/8/2016)... LAVAL, Quebec , Dec. 8, 2016 /PRNewswire/ ... and TSX: VRX) ("Valeant") today announced positive ... vehicle-controlled clinical study to assess the safety and ... in the treatment of plaque psoriasis. ... adult subjects with moderate to severe psoriasis, IDP-118 ...
Breaking Medicine Technology:
(Date:12/10/2016)... (PRWEB) , ... December 10, 2016 , ... When faced ... worried about germs spreading from the seat to her body, and contamination of children ... and effective way to solve this problem that many people face. , The patent-pending ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... planning assistance from offices in Pasco and Richland, is initiating a charity drive ... serious injuries resulting from a recent automobile collision. , On October 29th ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... pharmaceutical inserts and outserts. As a means of expanding capabilities Flottman has ... enable Flottman to individually code professional inserts (PIs) and patient package inserts (PPIs) ...
(Date:12/9/2016)... ... 09, 2016 , ... The Justin Veatch Fund announced Thursday that ... the film Whispering Spirits and its discussion guide for use by all ... tool in the war against teen drug abuse. NCADD is the oldest anti-addiction ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
Breaking Medicine News(10 mins):